Comments
Loading...

Akari Therapeutics

AKTXNASDAQ
Logo brought to you by Benzinga Data
$3.40
0.268.28%
Pre-Market: 9:25 AM EDT
15 minutes delayed

Akari Therapeutics (NASDAQ:AKTX) Stock, Earnings Estimates, EPS, And Revenue

Akari Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 19
EPS
$0.000
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)

Analyze the earnings history of Akari Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Akari Therapeutics (AKTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %

Akari Therapeutics (AKTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?

A

Akari Therapeutics (AKTX) is scheduled to report earnings on November 19, 2024. The last reported earnings were for reported on August 19, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Akari Therapeutics (NASDAQ:AKTX)?

A

The Actual EPS was $0.00, which hit the estimate of $0.00.

Q

What were Akari Therapeutics’s (NASDAQ:AKTX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch